Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
- PMID: 2040013
- DOI: 10.1016/0092-8674(91)90384-b
Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
Abstract
Activating mutations of p53 promote tumor progression. The mutant protein adopts a characteristic conformation, which lacks the growth suppressor function of wild-type p53. We show that mutant p53 can drive cotranslated wild-type p53 into the mutant conformation: a similar effect in vivo would block wild-type suppressor function with dominant negative effect. The cotranslational effect of mutant p53 on wild-type conformation depends upon interaction between nascent polypeptides and oligomerization of the full-length proteins. We also show that oligomers of p53 proteins can be induced to change conformation in a cooperative manner. Cell growth stimulation induces a similar conformational change in p53, and our present results indicate that this may involve allosteric regulation.
Similar articles
-
Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.Mol Cell Biol. 1991 Jan;11(1):12-9. doi: 10.1128/mcb.11.1.12-19.1991. Mol Cell Biol. 1991. PMID: 1986215 Free PMC article.
-
Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.Protein Sci. 1999 Sep;8(9):1773-9. doi: 10.1110/ps.8.9.1773. Protein Sci. 1999. PMID: 10493578 Free PMC article.
-
A conformation hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer.Proc Biol Sci. 1991 Aug 22;245(1313):139-45. doi: 10.1098/rspb.1991.0100. Proc Biol Sci. 1991. PMID: 1682937 Review.
-
Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.Cancer Res. 1993 Oct 1;53(19):4469-73. Cancer Res. 1993. PMID: 8402615
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
Cited by
-
Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.Mol Cell Biol. 1992 Dec;12(12):5581-92. doi: 10.1128/mcb.12.12.5581-5592.1992. Mol Cell Biol. 1992. PMID: 1448088 Free PMC article.
-
Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect.Nat Commun. 2019 Dec 5;10(1):5566. doi: 10.1038/s41467-019-13485-8. Nat Commun. 2019. PMID: 31804482 Free PMC article.
-
TP53-Associated Pediatric Malignancies.Genes Cancer. 2011 Apr;2(4):485-90. doi: 10.1177/1947601911409745. Genes Cancer. 2011. PMID: 21779516 Free PMC article.
-
The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding.EMBO J. 1995 Feb 1;14(3):512-9. doi: 10.1002/j.1460-2075.1995.tb07027.x. EMBO J. 1995. PMID: 7859740 Free PMC article.
-
Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8379-83. doi: 10.1073/pnas.93.16.8379. Proc Natl Acad Sci U S A. 1996. PMID: 8710879 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous